Healthy volunteers test new nerandomilast formulation and food effects
NCT ID NCT06624072
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This completed Phase 1 trial enrolled 15 healthy adults to compare two different formulations of the drug nerandomilast and to see if food affects how the new formulation is absorbed. Participants received single doses in a crossover design. The study focuses on drug levels in the blood, not on treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nerandomilast (also known as BI 1015550, JASCAYD®)
What this could lead to
If successful, this study could help determine the best formulation and dosing instructions for nerandomilast, potentially improving how it is taken in future trials.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only measures how the drug moves through the body, not whether it works for any disease. Results may not predict real-world effects.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.